Royalty Pharma (NASDAQ: RPRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Royalty Pharma (NASDAQ: RPRX) through any online brokerage.
The latest price target for Royalty Pharma (NASDAQ: RPRX) was reported by Tigress Financial on Thursday, July 14, 2022. The analyst firm set a price target for 57.00 expecting RPRX to rise to within 12 months (a possible 34.28% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $42.45 last updated August 5, 2022, 8:00 PM UTC.
The next Royalty Pharma (RPRX) dividend date is projected to be Thursday, August 18, 2022.
Royalty Pharma’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.